CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
PGX Technology
PGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGX
Stock Information CZO
TSX Venture
CZO
Change
Volume
Day Range
52 Week Range
Stock Information CRPOF
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Corporate Presentation
View our latest corporate presentation to learn more about Ceapro, our products and our proprietary manufacturing technology.
View Presentation
Products
Ceapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Latest News
Ceapro to Present at the Virtual Investor 2023 Companies to Watch Event
Jan 10, 2023 | Read More
Ceapro Announces Grant of Stock Options
Jan 4, 2023 | Read More
Ceapro Inc. Receives Approval from Health Canada to Commence Phase 1/2a Human Clinical Trial Assessing Avenanthramide Tablets
Dec 22, 2022 | Read More
Ceapro Inc. Reports 2022 Third Quarter and Nine-Month Financial Results and Operational Highlights
Nov 9, 2022 | Read More